ID   CPT1A_HUMAN             Reviewed;         773 AA.
AC   P50416; Q8TCU0; Q9BWK0;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 2.
DT   10-MAY-2017, entry version 166.
DE   RecName: Full=Carnitine O-palmitoyltransferase 1, liver isoform;
DE            Short=CPT1-L;
DE            EC=2.3.1.21;
DE   AltName: Full=Carnitine O-palmitoyltransferase I, liver isoform;
DE            Short=CPT I;
DE            Short=CPTI-L;
DE   AltName: Full=Carnitine palmitoyltransferase 1A;
GN   Name=CPT1A; Synonyms=CPT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7892212; DOI=10.1073/pnas.92.6.1984;
RA   Britton C.H., Schultz R.A., Zhang B., Esser V., Foster D.W.,
RA   McGarry J.D.;
RT   "Human liver mitochondrial carnitine palmitoyltransferase I:
RT   characterization of its cDNA and chromosomal localization and partial
RT   analysis of the gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:1984-1988(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CPT1AD VAL-414 AND
RP   CYS-498, AND VARIANT THR-275.
RX   PubMed=12189492; DOI=10.1007/s00439-002-0752-0;
RA   Gobin S., Bonnefont J.-P., Prip-Buus C., Mugnier C., Ferrec M.,
RA   Demaugre F., Saudubray J.-M., Rostane H., Djouadi F., Wilcox W.,
RA   Cederbaum S., Haas R., Nyhan W.L., Green A., Gray G., Girard J.,
RA   Thuillier L.;
RT   "Organization of the human liver carnitine palmitoyltransferase 1 gene
RT   (CPT1A) and identification of novel mutations in hypoketotic
RT   hypoglycaemia.";
RL   Hum. Genet. 111:179-189(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INDUCTION BY FATTY ACIDS.
RX   PubMed=16271724; DOI=10.1016/j.jmb.2005.09.097;
RA   Napal L., Marrero P.F., Haro D.;
RT   "An intronic peroxisome proliferator-activated receptor-binding
RT   sequence mediates fatty acid induction of the human carnitine
RT   palmitoyltransferase 1A.";
RL   J. Mol. Biol. 354:751-759(2005).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [8]
RP   3D-STRUCTURE MODELING.
RX   PubMed=14711372; DOI=10.1042/BJ20031373;
RA   Morillas M., Lopez-Vinas E., Valencia A., Serra D., Gomez-Puertas P.,
RA   Hegardt F.G., Asins G.;
RT   "Structural model of carnitine palmitoyltransferase I based on the
RT   carnitine acetyltransferase crystal.";
RL   Biochem. J. 379:777-784(2004).
RN   [9]
RP   STRUCTURE BY NMR OF 1-42, AND DOMAIN.
RX   PubMed=21990363; DOI=10.1074/jbc.M111.306951;
RA   Rao J.N., Warren G.Z., Estolt-Povedano S., Zammit V.A., Ulmer T.S.;
RT   "An environment-dependent structural switch underlies the regulation
RT   of carnitine palmitoyltransferase 1A.";
RL   J. Biol. Chem. 286:42545-42554(2011).
RN   [10]
RP   VARIANT CPT1AD GLY-454.
RX   PubMed=9691089; DOI=10.1172/JCI2927;
RA   IJlst L., Mandel H., Oostheim W., Ruiter J.P.N., Gutman A.,
RA   Wanders R.J.;
RT   "Molecular basis of hepatic carnitine palmitoyltransferase I
RT   deficiency.";
RL   J. Clin. Invest. 102:527-531(1998).
RN   [11]
RP   VARIANTS CPT1AD CYS-123; TRP-304; TRP-357; ARG-395 DEL; LEU-479 AND
RP   PRO-484, AND VARIANT THR-275.
RX   PubMed=11441142;
RA   Brown N.F., Mullur R.S., Subramanian I., Esser V., Bennett M.J.,
RA   Saudubray J.-M., Feigenbaum A.S., Kobari J.A., Macleod P.M.,
RA   McGarry J.D., Cohen J.C.;
RT   "Molecular characterization of L-CPT I deficiency in six patients:
RT   insights into function of the native enzyme.";
RL   J. Lipid Res. 42:1134-1142(2001).
RN   [12]
RP   VARIANT CPT1AD GLU-710, CHARACTERIZATION OF VARIANT CPT1AD GLU-710,
RP   CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11350182; DOI=10.1006/mgme.2001.3176;
RA   Prip-Buus C., Thuillier L., Abadi N., Prasad C., Dilling L.,
RA   Klasing J., Demaugre F., Greenberg C.R., Haworth J.C., Droin V.,
RA   Kadhom N., Gobin S., Kamoun P., Girard J., Bonnefont J.-P.;
RT   "Molecular and enzymatic characterization of a unique carnitine
RT   palmitoyltransferase 1A mutation in the Hutterite community.";
RL   Mol. Genet. Metab. 73:46-54(2001).
RN   [13]
RP   CHARACTERIZATION OF VARIANT CPT1AD GLY-360.
RX   PubMed=12111367; DOI=10.1007/s100380200047;
RA   Ogawa E., Kanazawa M., Yamamoto S., Ohtsuka S., Ogawa A., Ohtake A.,
RA   Takayanagi M., Kohno Y.;
RT   "Expression analysis of two mutations in carnitine
RT   palmitoyltransferase IA deficiency.";
RL   J. Hum. Genet. 47:342-347(2002).
RN   [14]
RP   VARIANT CPT1AD GLU-709, CHARACTERIZATION OF VARIANTS CPT1AD THR-275;
RP   VAL-414; CYS-498; GLU-709 AND GLU-710, SUBCELLULAR LOCATION, CATALYTIC
RP   ACTIVITY, AND ENZYME REGULATION.
RX   PubMed=14517221; DOI=10.1074/jbc.M310130200;
RA   Gobin S., Thuillier L., Jogl G., Faye A., Tong L., Chi M.,
RA   Bonnefont J.-P., Girard J., Prip-Buus C.;
RT   "Functional and structural basis of carnitine palmitoyltransferase 1A
RT   deficiency.";
RL   J. Biol. Chem. 278:50428-50434(2003).
RN   [15]
RP   VARIANT CPT1AD ILE-314.
RX   PubMed=15669684; DOI=10.1023/B:BOLI.0000042979.42120.55;
RA   Stoler J.M., Sabry M.A., Hanley C., Hoppel C.L., Shih V.E.;
RT   "Successful long-term treatment of hepatic carnitine
RT   palmitoyltransferase I deficiency and a novel mutation.";
RL   J. Inherit. Metab. Dis. 27:679-684(2004).
RN   [16]
RP   VARIANTS CPT1AD GLY-316; VAL-343 AND TRP-465.
RX   PubMed=15110323; DOI=10.1016/j.ymgme.2004.02.004;
RA   Bennett M.J., Boriack R.L., Narayan S., Rutledge S.L., Raff M.L.;
RT   "Novel mutations in CPT 1A define molecular heterogeneity of hepatic
RT   carnitine palmitoyltransferase I deficiency.";
RL   Mol. Genet. Metab. 82:59-63(2004).
CC   -!- FUNCTION: Catalyzes the transfer of the acyl group of long-chain
CC       fatty acid-CoA conjugates onto carnitine, an essential step for
CC       the mitochondrial uptake of long-chain fatty acids and their
CC       subsequent beta-oxidation in the mitochondrion. Plays an important
CC       role in triglyceride metabolism.
CC   -!- CATALYTIC ACTIVITY: Palmitoyl-CoA + L-carnitine = CoA + L-
CC       palmitoylcarnitine. {ECO:0000269|PubMed:11350182,
CC       ECO:0000269|PubMed:14517221}.
CC   -!- ENZYME REGULATION: Inhibited by malonyl-CoA.
CC       {ECO:0000269|PubMed:14517221}.
CC   -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
CC   -!- SUBUNIT: Homohexamer and homotrimer. Identified in a complex that
CC       contains at least CPT1A, ACSL1 and VDAC1. Also identified in
CC       complexes with ACSL1 and VDAC2 and VDAC3 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
CC       {ECO:0000269|PubMed:11350182, ECO:0000269|PubMed:14517221}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:11350182,
CC       ECO:0000269|PubMed:14517221}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P50416-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P50416-2; Sequence=VSP_012167;
CC   -!- TISSUE SPECIFICITY: Strong expression in kidney and heart, and
CC       lower in liver and skeletal muscle.
CC   -!- INDUCTION: Up-regulated by fatty acids.
CC       {ECO:0000269|PubMed:16271724}.
CC   -!- DOMAIN: A conformation change in the N-terminal region spanning
CC       the first 42 residues plays an important role in the regulation of
CC       enzyme activity by malonyl-CoA. {ECO:0000269|PubMed:21990363}.
CC   -!- DISEASE: Carnitine palmitoyltransferase 1A deficiency (CPT1AD)
CC       [MIM:255120]: Rare autosomal recessive metabolic disorder of long-
CC       chain fatty acid oxidation characterized by severe episodes of
CC       hypoketotic hypoglycemia usually occurring after fasting or
CC       illness. Onset is in infancy or early childhood.
CC       {ECO:0000269|PubMed:11350182, ECO:0000269|PubMed:11441142,
CC       ECO:0000269|PubMed:12111367, ECO:0000269|PubMed:12189492,
CC       ECO:0000269|PubMed:14517221, ECO:0000269|PubMed:15110323,
CC       ECO:0000269|PubMed:15669684, ECO:0000269|PubMed:9691089}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the carnitine/choline acetyltransferase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L39211; AAC41748.1; -; mRNA.
DR   EMBL; AJ420747; CAD12625.1; -; Genomic_DNA.
DR   EMBL; AJ420748; CAD59673.1; -; Genomic_DNA.
DR   EMBL; BT009791; AAP88793.1; -; mRNA.
DR   EMBL; BC000185; AAH00185.1; -; mRNA.
DR   CCDS; CCDS31624.1; -. [P50416-2]
DR   CCDS; CCDS8185.1; -. [P50416-1]
DR   PIR; I59351; I59351.
DR   RefSeq; NP_001027017.1; NM_001031847.2. [P50416-2]
DR   RefSeq; NP_001867.2; NM_001876.3. [P50416-1]
DR   RefSeq; XP_016872709.1; XM_017017220.1. [P50416-1]
DR   UniGene; Hs.503043; -.
DR   PDB; 2LE3; NMR; -; A=1-42.
DR   PDBsum; 2LE3; -.
DR   ProteinModelPortal; P50416; -.
DR   SMR; P50416; -.
DR   BioGrid; 107765; 43.
DR   IntAct; P50416; 27.
DR   MINT; MINT-3018357; -.
DR   STRING; 9606.ENSP00000265641; -.
DR   BindingDB; P50416; -.
DR   ChEMBL; CHEMBL1293194; -.
DR   DrugBank; DB01016; Glyburide.
DR   DrugBank; DB00583; L-Carnitine.
DR   DrugBank; DB01074; Perhexiline.
DR   SwissLipids; SLP:000001056; -.
DR   iPTMnet; P50416; -.
DR   PhosphoSitePlus; P50416; -.
DR   SwissPalm; P50416; -.
DR   BioMuta; CPT1A; -.
DR   DMDM; 56405343; -.
DR   EPD; P50416; -.
DR   MaxQB; P50416; -.
DR   PaxDb; P50416; -.
DR   PeptideAtlas; P50416; -.
DR   PRIDE; P50416; -.
DR   DNASU; 1374; -.
DR   Ensembl; ENST00000265641; ENSP00000265641; ENSG00000110090. [P50416-1]
DR   Ensembl; ENST00000376618; ENSP00000365803; ENSG00000110090. [P50416-2]
DR   Ensembl; ENST00000539743; ENSP00000446108; ENSG00000110090. [P50416-1]
DR   Ensembl; ENST00000540367; ENSP00000439084; ENSG00000110090. [P50416-2]
DR   GeneID; 1374; -.
DR   KEGG; hsa:1374; -.
DR   UCSC; uc001oof.5; human. [P50416-1]
DR   CTD; 1374; -.
DR   DisGeNET; 1374; -.
DR   GeneCards; CPT1A; -.
DR   GeneReviews; CPT1A; -.
DR   HGNC; HGNC:2328; CPT1A.
DR   HPA; HPA008835; -.
DR   MalaCards; CPT1A; -.
DR   MIM; 255120; phenotype.
DR   MIM; 600528; gene.
DR   neXtProt; NX_P50416; -.
DR   OpenTargets; ENSG00000110090; -.
DR   Orphanet; 156; Carnitine palmitoyl transferase 1A deficiency.
DR   PharmGKB; PA26847; -.
DR   eggNOG; KOG3717; Eukaryota.
DR   eggNOG; ENOG410XNZ9; LUCA.
DR   GeneTree; ENSGT00760000119220; -.
DR   HOGENOM; HOG000233542; -.
DR   HOVERGEN; HBG003458; -.
DR   InParanoid; P50416; -.
DR   KO; K08765; -.
DR   OMA; HIVVFHK; -.
DR   OrthoDB; EOG091G026C; -.
DR   PhylomeDB; P50416; -.
DR   TreeFam; TF313836; -.
DR   BioCyc; MetaCyc:HS03286-MONOMER; -.
DR   BRENDA; 2.3.1.21; 2681.
DR   Reactome; R-HSA-1368082; RORA activates gene expression.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-200425; Import of palmitoyl-CoA into the mitochondrial matrix.
DR   Reactome; R-HSA-5362517; Signaling by Retinoic Acid.
DR   SABIO-RK; P50416; -.
DR   UniPathway; UPA00659; -.
DR   ChiTaRS; CPT1A; human.
DR   GenomeRNAi; 1374; -.
DR   PRO; PR:P50416; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000110090; -.
DR   CleanEx; HS_CPT1A; -.
DR   ExpressionAtlas; P50416; baseline and differential.
DR   Genevisible; P50416; HS.
DR   GO; GO:0031307; C:integral component of mitochondrial outer membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005741; C:mitochondrial outer membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0004095; F:carnitine O-palmitoyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:1990698; F:palmitoleoyltransferase activity; IEA:Ensembl.
DR   GO; GO:0009437; P:carnitine metabolic process; IDA:UniProtKB.
DR   GO; GO:0006853; P:carnitine shuttle; TAS:Reactome.
DR   GO; GO:0071398; P:cellular response to fatty acid; IEA:Ensembl.
DR   GO; GO:0007623; P:circadian rhythm; TAS:Reactome.
DR   GO; GO:0042755; P:eating behavior; IEA:Ensembl.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; TAS:ProtInc.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:Ensembl.
DR   GO; GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0032000; P:positive regulation of fatty acid beta-oxidation; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0050796; P:regulation of insulin secretion; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0006641; P:triglyceride metabolic process; IEA:Ensembl.
DR   InterPro; IPR000542; Carn_acyl_trans.
DR   InterPro; IPR032476; CPT_N.
DR   PANTHER; PTHR22589; PTHR22589; 1.
DR   Pfam; PF00755; Carn_acyltransf; 1.
DR   Pfam; PF16484; CPT_N; 1.
DR   PROSITE; PS00439; ACYLTRANSF_C_1; 1.
DR   PROSITE; PS00440; ACYLTRANSF_C_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Alternative splicing;
KW   Complete proteome; Disease mutation; Fatty acid metabolism;
KW   Lipid metabolism; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; Nitration; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix;
KW   Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P32198}.
FT   CHAIN         2    773       Carnitine O-palmitoyltransferase 1, liver
FT                                isoform.
FT                                /FTId=PRO_0000210159.
FT   TOPO_DOM      2     47       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     48     73       Helical. {ECO:0000255}.
FT   TOPO_DOM     74    102       Mitochondrial intermembrane.
FT                                {ECO:0000255}.
FT   TRANSMEM    103    122       Helical. {ECO:0000255}.
FT   TOPO_DOM    123    773       Cytoplasmic. {ECO:0000255}.
FT   REGION      555    567       Coenzyme A binding. {ECO:0000250}.
FT   ACT_SITE    473    473       Proton acceptor. {ECO:0000250}.
FT   BINDING     589    589       Carnitine. {ECO:0000250}.
FT   BINDING     602    602       Carnitine. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000250|UniProtKB:P32198}.
FT   MOD_RES     282    282       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:P32198}.
FT   MOD_RES     588    588       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P32198}.
FT   MOD_RES     589    589       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:P32198}.
FT   MOD_RES     604    604       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P32198}.
FT   MOD_RES     741    741       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P32198}.
FT   MOD_RES     747    747       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P32198}.
FT   VAR_SEQ     746    773       DSHRFGRHLKEAMTDIITLFGLSSNSKK -> GIISQGPSS
FT                                DT (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_012167.
FT   VARIANT     123    123       R -> C (in CPT1AD; dbSNP:rs80356775).
FT                                {ECO:0000269|PubMed:11441142}.
FT                                /FTId=VAR_020546.
FT   VARIANT     275    275       A -> T (in dbSNP:rs2229738).
FT                                {ECO:0000269|PubMed:11441142,
FT                                ECO:0000269|PubMed:12189492,
FT                                ECO:0000269|PubMed:14517221}.
FT                                /FTId=VAR_020547.
FT   VARIANT     304    304       C -> W (in CPT1AD; dbSNP:rs80356789).
FT                                {ECO:0000269|PubMed:11441142}.
FT                                /FTId=VAR_020548.
FT   VARIANT     314    314       T -> I (in CPT1AD; dbSNP:rs80356776).
FT                                {ECO:0000269|PubMed:15669684}.
FT                                /FTId=VAR_020549.
FT   VARIANT     316    316       R -> G (in CPT1AD; dbSNP:rs80356796).
FT                                {ECO:0000269|PubMed:15110323}.
FT                                /FTId=VAR_046767.
FT   VARIANT     343    343       F -> V (in CPT1AD; dbSNP:rs80356783).
FT                                {ECO:0000269|PubMed:15110323}.
FT                                /FTId=VAR_046768.
FT   VARIANT     357    357       R -> W (in CPT1AD; decreased stability;
FT                                dbSNP:rs80356777).
FT                                {ECO:0000269|PubMed:11441142}.
FT                                /FTId=VAR_020550.
FT   VARIANT     360    360       E -> G (in CPT1AD; reduced protein
FT                                levels; dbSNP:rs28936372).
FT                                {ECO:0000269|PubMed:12111367}.
FT                                /FTId=VAR_020551.
FT   VARIANT     395    395       Missing (in CPT1AD; loss of activity).
FT                                {ECO:0000269|PubMed:11441142}.
FT                                /FTId=VAR_020552.
FT   VARIANT     414    414       A -> V (in CPT1AD; decreased activity;
FT                                dbSNP:rs28936373).
FT                                {ECO:0000269|PubMed:12189492,
FT                                ECO:0000269|PubMed:14517221}.
FT                                /FTId=VAR_020553.
FT   VARIANT     454    454       D -> G (in CPT1AD; dbSNP:rs80356778).
FT                                {ECO:0000269|PubMed:9691089}.
FT                                /FTId=VAR_020554.
FT   VARIANT     465    465       G -> W (in CPT1AD; dbSNP:rs80356784).
FT                                {ECO:0000269|PubMed:15110323}.
FT                                /FTId=VAR_046769.
FT   VARIANT     479    479       P -> L (in CPT1AD; decreased activity;
FT                                dbSNP:rs80356779).
FT                                {ECO:0000269|PubMed:11441142}.
FT                                /FTId=VAR_020555.
FT   VARIANT     484    484       L -> P (in CPT1AD; dbSNP:rs80356793).
FT                                {ECO:0000269|PubMed:11441142}.
FT                                /FTId=VAR_020556.
FT   VARIANT     498    498       Y -> C (in CPT1AD; decreased activity;
FT                                dbSNP:rs80356791).
FT                                {ECO:0000269|PubMed:12189492,
FT                                ECO:0000269|PubMed:14517221}.
FT                                /FTId=VAR_020557.
FT   VARIANT     709    709       G -> E (in CPT1AD; loss of activity;
FT                                dbSNP:rs28936374).
FT                                {ECO:0000269|PubMed:14517221}.
FT                                /FTId=VAR_020558.
FT   VARIANT     710    710       G -> E (in CPT1AD; loss of activity;
FT                                dbSNP:rs80356780).
FT                                {ECO:0000269|PubMed:11350182,
FT                                ECO:0000269|PubMed:14517221}.
FT                                /FTId=VAR_020559.
FT   CONFLICT    479    479       P -> Q (in Ref. 1; AAC41748).
FT                                {ECO:0000305}.
FT   CONFLICT    568    568       A -> T (in Ref. 1; AAC41748).
FT                                {ECO:0000305}.
FT   HELIX         4      7       {ECO:0000244|PDB:2LE3}.
FT   STRAND        9     15       {ECO:0000244|PDB:2LE3}.
FT   STRAND       18     23       {ECO:0000244|PDB:2LE3}.
FT   HELIX        25     39       {ECO:0000244|PDB:2LE3}.
SQ   SEQUENCE   773 AA;  88368 MW;  E5DC9141B6301947 CRC64;
     MAEAHQAVAF QFTVTPDGID LRLSHEALRQ IYLSGLHSWK KKFIRFKNGI ITGVYPASPS
     SWLIVVVGVM TTMYAKIDPS LGIIAKINRT LETANCMSSQ TKNVVSGVLF GTGLWVALIV
     TMRYSLKVLL SYHGWMFTEH GKMSRATKIW MGMVKIFSGR KPMLYSFQTS LPRLPVPAVK
     DTVNRYLQSV RPLMKEEDFK RMTALAQDFA VGLGPRLQWY LKLKSWWATN YVSDWWEEYI
     YLRGRGPLMV NSNYYAMDLL YILPTHIQAA RAGNAIHAIL LYRRKLDREE IKPIRLLGST
     IPLCSAQWER MFNTSRIPGE ETDTIQHMRD SKHIVVYHRG RYFKVWLYHD GRLLKPREME
     QQMQRILDNT SEPQPGEARL AALTAGDRVP WARCRQAYFG RGKNKQSLDA VEKAAFFVTL
     DETEEGYRSE DPDTSMDSYA KSLLHGRCYD RWFDKSFTFV VFKNGKMGLN AEHSWADAPI
     VAHLWEYVMS IDSLQLGYAE DGHCKGDINP NIPYPTRLQW DIPGECQEVI ETSLNTANLL
     ANDVDFHSFP FVAFGKGIIK KCRTSPDAFV QLALQLAHYK DMGKFCLTYE ASMTRLFREG
     RTETVRSCTT ESCDFVRAMV DPAQTVEQRL KLFKLASEKH QHMYRLAMTG SGIDRHLFCL
     YVVSKYLAVE SPFLKEVLSE PWRLSTSQTP QQQVELFDLE NNPEYVSSGG GFGPVADDGY
     GVSYILVGEN LINFHISSKF SCPETDSHRF GRHLKEAMTD IITLFGLSSN SKK
//
